Sort   by:  
 Page size 
UnknownNKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
Not available
S-EPMC5564787 | biostudies-literature
UnknownAngiogenic Potential of Small Extracellular Vesicles Produced by Stimulated Mesenchymal Stromal Cells Under Hypoxic Conditions.
Not available
S-EPMC12820520 | biostudies-literature
UnknownNKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML.
Not available
S-EPMC5706596 | biostudies-literature
UnknownNatural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.
Not available
S-EPMC5447002 | biostudies-literature
UnknownProspective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
Not available
S-EPMC4815724 | biostudies-literature
UnknownLow frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia.
Not available
S-EPMC11372596 | biostudies-literature
UnknownCompound genetic etiology in a patient with a syndrome including diabetes, intellectual deficiency and distichiasis.
Not available
S-EPMC8887189 | biostudies-literature
UnknownRoutine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples.
Not available
S-EPMC3284426 | biostudies-literature
UnknownImprovement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience.
Not available
S-EPMC8598224 | biostudies-literature
UnknownHaematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
Not available
S-EPMC4845427 | biostudies-literature
Sort   by:  
 Page size